Artimplant to take over responsibility for sales of Artelon CMC Spacer

With effect from January 1, 2012, Artimplant will take over responsibility for sales of Artelon® CMC Spacer, previously handled by the licensee SBi. This is an integral part of Artimplant's focus on reinforcing its presence on the very important US market.

Since December 2011, Artimplant has had a stronger sales organization in place in the USA, which it is felt will contribute positively to the company's presence and sales volumes. By assuming responsibility for sales of Artelon® CMC Spacer and other products for restoring joint surfaces, Artimplant will have a more complete product offering on the US market. Artelon® CMC Spacer is considered to have major market potential, which Artimplant is in a better position to develop by assuming direct control of sales.

The former licensee, SBI, will cease sales of Artimplant products for restoring joint surfaces in conjunction with Artimplant taking back the sales rights for these products.

Source:

Artimplant

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.